Skip to main content
PeptiDex Logo

PeptiDex

Peptide Research Index

Research-backed

⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

Privacy & Terms
Home
Library
StartToolsSaved
Back to Library

⚠️ Educational only · Not medical advice · Consult a doctor · Most peptides are research-only / not FDA-approved for human use

NAD+

Also: Nicotinamide Adenine Dinucleotide, NAD Plus, Beta-Nicotinamide Adenine Dinucleotide

⚡Longevity

How It Works

NAD+ is a critical coenzyme in every cell, essential for mitochondrial energy production (oxidative phosphorylation), DNA repair via PARP and sirtuin activation, and circadian rhythm regulation. Levels decline ~50% between ages 40-60, contributing to metabolic dysfunction and aging.

Primary Benefits

1Cellular energy
2DNA repair
3longevity

Key Studies

NAD+ decline is a driver of aging

Rajman et al. (Cell Metabolism): Comprehensive review demonstrating NAD+ decline as a hallmark of aging, with restoration improving mitochondrial function, stem cell renewal, and lifespan in animal models.

strong

NAD+ repletion improves mitochondrial and stem cell function

Zhang et al. (Science): NAD+ supplementation restores mitochondrial function in aged mice, improving muscle stem cell function and extending lifespan.

preclinical

CD38 dictates age-related NAD decline and mitochondrial dysfunction

Camacho-Pereira et al. (Cell Metabolism): Identifies CD38 as the primary NAD-consuming enzyme that increases with age, explaining the progressive NAD+ decline.

preclinical

NAD+ intermediates: NMN and NR clinical trial overview

Yoshino et al.: Review of human clinical trials for NAD+ precursors (NMN, NR) showing safe elevation of blood NAD+ levels with improvements in insulin sensitivity and muscle function.

moderate

Safety Notes

Generally well-tolerated. IV NAD+ infusions may cause chest tightness, nausea, and cramping during administration. Subcutaneous injection is better tolerated. Oral precursors (NMN, NR) have good safety profiles in clinical trials.

Dosing Protocol

⚠️ For educational purposes only. Not medical advice. Consult a healthcare professional before using any peptide.

RouteSubQ
Dose Range50000-200000 mcg
FrequencyDaily
TimingMorning
Cycle Length4-12 weeks
BAC Water2 ml / 500mg vial

SubQ: 50-200mg daily. IV: 250-500mg over 2-4 hours. Start low — rapid NAD+ elevation can cause nausea and flushing. Oral precursors (NMN/NR) are an alternative.

Half-Life Visualization

⏱️ Half-Life: 4h

Plasma concentration over time
100%50%0%0t½ = 4h

Expected Timeline

Week 1

Increased energy, mental clarity, reduced brain fog

Weeks 2-4

Improved exercise recovery, better sleep quality, mood stabilization

Month 2-3

Measurable improvements in metabolic markers, sustained energy throughout the day

Long-term

NAD+ level restoration; potential longevity benefits (animal data for lifespan extension)

Side Effects & Incidence

Side EffectIncidenceSeverity

Nausea during infusion

Dose-dependent; resolved by slowing infusion rate

~30% (IV route)moderate

Flushing/warmth

~20% of usersmild

Chest tightness

Transient during infusion, resolves within minutes

~15% (IV route)mild

Injection site discomfort

~10% (SubQ)mild

Incidence rates sourced from published clinical trial data where available; otherwise based on community research observations.

Weekly Peptide Research

New studies · vendor alerts · protocol tips

No spam. Unsubscribe anytime. Research use only.